BioCardia, Inc. (BCDA) — Financial statements
Income statement, balance sheet, and cash flow for BioCardia, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00↓100.0% | 0.06↓87.8% | 0.48↓64.7% | 1↑33.2% | 1 | |
| Cost of Revenue | 0.51↓88.5% | 4↓43.2% | 8↓12.5% | 9↑1280.3% | 0.64 | |
| Gross Profit | -0.51↑88.3% | -4↑40.3% | -7↑3.1% | -7↓2095.2% | 0.38 | |
| Operating Expenses | ||||||
| R&D Expenses | 5↑13.1% | 4↓43.2% | 8↓12.5% | 9↑3.2% | 9 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 3 | 0.00 | 0.00 | 0.00↓100.0% | 5 | |
| Other Expenses | -0.51↑29.4% | -0.72↑78.5% | -3↑24.6% | -4↓589.8% | -0.64 | |
| Operating Expenses | 8↑111.7% | 4↓16.5% | 4↓0.5% | 4↓66.0% | 13 | |
| Total Costs & Expenses | 8↑2.7% | 8↓33.5% | 12↓8.5% | 13↓2.9% | 14 | |
| Operating Results | ||||||
| Operating Income | -8↓3.5% | -8↑31.3% | -12↑2.2% | -12↑5.8% | -13 | |
| Depreciation & Amortization | 0.51↑653.7% | 0.07↓20.2% | 0.08↑2.4% | 0.08↑36.7% | 0.06 | |
| EBITDA | -8↑2.0% | -8↑31.4% | -12↑2.2% | -12↑6.0% | -13 | |
| EBIT | -8↓3.5% | -8↑31.3% | -12↑2.2% | -12↑5.8% | -13 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00 | 0.00 | 0.00↑100.0% | -0.01↓166.7% | 0.01 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.01 | |
| Interest Expense | 0.00 | 0.00 | 0.00↓100.0% | 0.01 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00↑100.0% | -0.01 | |
| Other Income / Expenses | 0.05↓9.1% | 0.05↓24.7% | 0.07↑1316.7% | -0.01↓185.7% | 0.01 | |
| Income Before Tax | -8↓3.5% | -8↑31.3% | -12↑2.8% | -12↑5.7% | -13 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -8↓3.5% | -8↑31.3% | -12↑2.8% | -12↑5.7% | -13 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -8↓3.5% | -8↑31.3% | -12↑2.8% | -12↑5.7% | -13 | |
| Bottom-Line Net Income | -8↓3.5% | -8↑31.3% | -12↑2.8% | -12↑5.7% | -13 | |
| EPS (Basic) | -1.23↑57.6% | -2.90↑64.6% | -8.19↑18.5% | -10.05↑10.2% | -11.19 | |
| EPS (Diluted) | -1.23↑57.6% | -2.90↑64.6% | -8.19↑18.5% | -10.05↑10.2% | -11.19 | |
| Weighted Average Shares | 7↑143.0% | 3↑94.3% | 1↑19.6% | 1↑4.7% | 1 | |
| Weighted Average Diluted Shares | 7↑143.0% | 3↑94.3% | 1↑19.6% | 1↑4.7% | 1 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.